Iqvia price target lowered to $235 from $240 at Baird

Baird lowered the firm’s price target on Iqvia to $235 from $240 and keeps an Outperform rating on the shares. The analyst said 1Q results largely in line with expectations, guidance unchanged, and universally positive RD&S demand commentary.